Ligand Pharmaceuticals Incorporated

États‑Unis d’Amérique


Commandez votre montre hebdomadaire Ligand Pharmaceuticals Incorporated
Quantité totale PI 170
Quantité totale incluant filiales 453 (+ 283 pour les filiales)
Rang # Quantité totale PI 7 767
Note d'activité PI 2,6/5.0    53
Rang # Activité PI 13 526
Activité incl filiales 2,7/5.0    137
Symbole boursier
ISIN US53220K5048
Capitalisation 2,400M  (USD)
Industrie Biotechnology
Secteur Healthcare
Classe Nice dominante Services scientifiques, technolo...

Brevets

Marques

94 10
10 4
45 6
1
 
Dernier brevet 2025 - Cyclic phosphoramidate compounds
Premier brevet 1992 - Use of selective ligands for tre...
Dernière marque 2025 - BEPRO
Première marque 1995 - LIGAND

Filiales

7 subsidiaries with IP (241 patents, 42 trademarks)

4 subsidiaries without IP

 S'inscrire grtuitement pour accéder à la liste des filiales

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 P/S Pharmaceutical research and development
2024 P/S Pharmaceutical research and development. Licensing of pharmaceutical products.
P/S Solubilizing chemical agents for use in the manufacture of pharmaceutical preparations; solubili...
P/S Pharmaceutical research and development Licensing of pharmaceutical products
P/S Solubilizing chemical agents for use in the manufacture of pharmaceutical preparations; Solubiliz...
2023 Invention Topical antiviral compositions, delivery systems, and methods of using the same. The present inve...
2022 Invention Nitric oxide-releasing nasal compositions and methods of use thereof. The present invention rela...
Invention Cyclic phosphoramidate compounds. Provided herein are cyclic phosphoramidate compounds, their pr...
Invention Cyclic phosphoramidate compounds. Provided herein are cyclic phosphoramidate compounds, their pre...
Invention Nucleotide prodrug compounds. Provided herein are nucleotide prodrug compounds, their preparation...
Invention Unnatural configuration nucleotide prodrug compounds. Provided herein am phosphoramidate and cyc...
Invention Unnatural configuration nucleotide prodrug compounds. Provided herein are phosphoramidate and cyc...
P/S Pharmaceutical research and development of a process to deliver pharmaceutical preparations.
Invention Topical compositions and methods of using the same. The present invention relates generally to c...
2021 Invention Heterocycle amines and uses thereof. Compounds and methods in the fields of chemistry and medicin...
Invention Antiviral prodrug compounds. Provided herein are nucleotide prodrug compounds, their preparation...
Invention Antiviral prodrug compounds. Provided herein are nucleotide prodrug compounds, their preparation ...
P/S Pharmaceutical research and development of a process to deliver pharmaceutical preparations
Invention Tunable nitric oxide-releasing macromolecules having multiple nitric oxide donor structures. Pro...
P/S Pharmaceutical research and development Licensing of pharmaceutical products
Invention Benzyloxy phosph(on)ate compounds. Provided herein are 2-substituted benzyloxy phosph(on)ate com...
Invention Benzyloxy phosph(on)ate compounds. Provided herein are 2-substituted benzyloxy phosph(on)ate comp...
2020 Invention Imidazo-fused heterocycles and uses thereof. Compounds and methods in the fields of chemistry and...
Invention Selective androgen receptor modulators (sarms) and uses thereof. Provided herein are compounds, s...
Invention Methods and compositions associated with the granulocyte colony-stimulating factor receptor. Some...
Invention Cyclic phosphate compounds. Provided herein are cyclic phosphate compounds, their preparation an...
Invention Cyclic phosphate compounds. Provided herein are cyclic phosphate compounds, their preparation and...
Invention Crystalline forms and methods of producing crystalline forms of a compound. Disclosed herein are ...
2019 Invention Topical compositions. Provided herein are anhydrous compositions that include at least one visco...
P/S Pharmaceutical research and development of a process to deliver organ specific pharmaceutical pre...
P/S Pharmaceutical research and development of a process to deliver organ specific pharmaceutical pr...
Invention Methods and compositions for modulating hormone levels. Provided herein are compositions and meth...
Invention Prodrug compounds and their uses. Provided herein are prodrug compounds, their preparation and th...
Invention Tunable nitric oxide-releasing macromolecules having multiple nitric oxide donor structures. Prov...
Invention Nitric oxide releasing suppositories and methods of use thereof. The present invention relates ge...
Invention Glucagon receptor antagonists. Provided herein are solid state forms of compounds, including enan...
Invention Topical compositions and methods of using the same. The present invention generally relates to to...
Invention Acetal compounds and therapeutic uses thereof. Disclosed herein are acetal and cyclic acetal comp...
2018 Invention Topical compositions. Provided herein are anhydrous compositions that include at least one viscos...
Invention Glucagon antagonists. Provided herein are compounds, including enantiomerically pure forms there...
Invention Topical compositions and methods of using the same. The present invention relates generally to co...
Invention Prodrug compounds and uses thereof. Provided herein are cyclic phosphorus-containing prodrug comp...
Invention Method for treating chronic inflammatory diseases. Methods of administering and pharmaceutical c...
2017 Invention Glucagon receptor antagonists. Provided herein are compounds, including enantiomerically pure fo...
Invention Compositions, systems, kits, and methods for treating an infection. Tinea pedis) infection.
Invention Compositions for treating inflammation and methods of treating the same. Provided herein are comp...
2016 P/S Licensing of pharmaceutical products
2001 P/S Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use...
1995 P/S Medicines for the treatment of cancer conditions. Medicines for the treatment of cancer and pre-c...